{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:02:38Z","timestamp":1792623758206,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":618,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA049219"],"award-info":[{"award-number":["K01DA049219"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jpain.2021.06.007","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T04:53:16Z","timestamp":1625028796000},"page":"45-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia"],"prefix":"10.1016","volume":"23","author":[{"given":"Kevin F.","family":"Boehnke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel J.","family":"Gagnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Matallana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2021.06.007_bib0001","unstructured":"US Food and Drug Administration: Warning Letters and Test results for cannabidiol-related products. Vol 4-15-2020, 2019."},{"key":"10.1016\/j.jpain.2021.06.007_bib0002","doi-asserted-by":"crossref","first-page":"ITC33","DOI":"10.7326\/AITC202003030","article-title":"Fibromyalgia","volume":"172","author":"Bair","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpain.2021.06.007_bib0003","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.jpain.2021.06.007_bib0004","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.2018.17722","article-title":"Pain management: Assembling a tool kit, building a life","volume":"320","author":"Boehnke","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2021.06.007_bib0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpain.2020.12.001","article-title":"Cannabidiol use for fibromyalgia: Prevalence of use and perceptions of effectiveness in a large online survey","volume":"22","author":"Boehnke","year":"2021","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2021.06.007_bib0006","doi-asserted-by":"crossref","unstructured":"Boehnke KF, Gagnier JJ, Matallana L, Williams DA. Substituting cannabidiol for opioids and pain medications among individuals with fibromyalgia: A large online survey. Published online May 12, 2021. doi: 10.1016\/j.jpain.2021.04.011","DOI":"10.1016\/j.jpain.2021.04.011"},{"key":"10.1016\/j.jpain.2021.06.007_bib0007","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1377\/hlthaff.2018.05266","article-title":"Qualifying conditions of medical cannabis license holders in the United States","volume":"38","author":"Boehnke","year":"2019","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jpain.2021.06.007_bib0008","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jpain.2016.03.002","article-title":"Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain","volume":"17","author":"Boehnke","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2021.06.007_bib0009","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jpain.2019.05.009","article-title":"Cannabis use preferences and decision-making among a cross-sectional cohort of medical cannabis patients with chronic pain","volume":"20","author":"Boehnke","year":"2019","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2021.06.007_bib0010","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jpain.2019.01.010","article-title":"Pills to pot: Observational analyses of cannabis substitution among medical cannabis users with chronic pain","volume":"20","author":"Boehnke","year":"2019","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2021.06.007_bib0011","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jama.2017.11909","article-title":"Labeling accuracy of cannabidiol extracts sold online","volume":"318","author":"Bonn-Miller","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2021.06.007_bib0012","unstructured":"Brenan M: 14% of Americans say they use CBD products. Available at: https:\/\/news.gallup.com\/poll\/263147\/americans-say-cbd-products.aspx Accessed April 21,2020, 2020"},{"key":"10.1016\/j.jpain.2021.06.007_bib0013","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/00325481.2019.1685298","article-title":"Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: A prospective cohort study","volume":"132","author":"Capano","year":"2020","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jpain.2021.06.007_bib0014","doi-asserted-by":"crossref","first-page":"417S","DOI":"10.1002\/j.1552-4604.1981.tb02622.x","article-title":"Hypnotic and antiepileptic effects of cannabidiol","volume":"21","author":"Carlini","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpain.2021.06.007_bib0015","doi-asserted-by":"crossref","unstructured":"Casey SL, Atwal N, Vaughan CW: Cannabis constituent synergy in a mouse neuropathic pain model, 2017.","DOI":"10.1097\/j.pain.0000000000001051"},{"key":"10.1016\/j.jpain.2021.06.007_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230167","article-title":"Mapping cannabis potency in medical and recreational programs in the United States","volume":"15","author":"Cash","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2021.06.007_bib0017","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrrheum.2010.120","article-title":"Pain management: Fibromyalgia drugs are 'as good as it gets' in chronic pain","volume":"6","author":"Clauw","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jpain.2021.06.007_bib0018","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: A clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2021.06.007_bib0019","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1089\/can.2019.0101","article-title":"Labeling of cannabidiol products: A public health perspective","volume":"117","author":"Corroon","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpain.2021.06.007_bib0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/can.2018.0006","article-title":"A cross-sectional study of cannabidiol users","volume":"3","author":"Corroon","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpain.2021.06.007_bib0021","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jpain.2021.06.007_bib0022","first-page":"394","article-title":"Medical fraud, mislabeling, contamination: all common in CBD products","volume":"117","author":"Evans","year":"2020","journal-title":"Mo Med"},{"key":"10.1016\/j.jpain.2021.06.007_bib0023","doi-asserted-by":"crossref","first-page":"108648","DOI":"10.1016\/j.drugalcdep.2021.108648","article-title":"Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles","volume":"221","author":"Fedorova","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpain.2021.06.007_bib0024","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/acr2.11138","article-title":"Medical cannabis use by rheumatology patients following recreational legalization: A prospective observational study of 1000 patients in Canada","volume":"2","author":"Fitzcharles","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jpain.2021.06.007_bib0025","doi-asserted-by":"crossref","first-page":"e18440","DOI":"10.1371\/journal.pone.0018440","article-title":"Cannabis use in patients with fibromyalgia: Effect on symptoms relief and health-related quality of life","volume":"6","author":"Fiz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2021.06.007_bib0026","series-title":"Arthritis Foundation: Patients Tell Us About CBD Use","year":"2020"},{"key":"10.1016\/j.jpain.2021.06.007_bib0027","article-title":"Use and perceptions of cannabidiol products in Canada and in the United States","author":"Goodman","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"issue":"Suppl.1-9","key":"10.1016\/j.jpain.2021.06.007_bib0028","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/19390211.2020.1766634","article-title":"Content versus label claims in cannabidiol (CBD)-containing products obtained from commercial outlets in the State of Mississippi","volume":"17","author":"Gurley","year":"2020","journal-title":"J Diet"},{"key":"10.1016\/j.jpain.2021.06.007_bib0029","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/can.2016.0024","article-title":"Training and practices of cannabis dispensary staff","volume":"1","author":"Haug","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpain.2021.06.007_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpain.2010.01.002","article-title":"Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome","volume":"11","author":"Hauser","year":"2010","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2021.06.007_bib0031","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: A double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpain.2021.06.007_bib0032","article-title":"Patterns of medical cannabis use among older adults from a cannabis dispensary in New York State","author":"Kaufmann","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpain.2021.06.007_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.13853","article-title":"Trends in internet searches for cannabidiol (CBD) in the United States","volume":"2","author":"Leas","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpain.2021.06.007_bib0034","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jpain.2021.06.007_bib0035","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fpsyg.2019.02466","article-title":"Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders","volume":"10","author":"Masataka","year":"2019","journal-title":"Front Psychol"},{"issue":"5","key":"10.1016\/j.jpain.2021.06.007_bib0036","article-title":"Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems","volume":"3","author":"Moltke","year":"2021","journal-title":"J Cannabis Res"},{"key":"10.1016\/j.jpain.2021.06.007_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.571832","article-title":"Cannabis contaminants limit pharmacological use of cannabidiol","volume":"11","author":"Montoya","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpain.2021.06.007_bib0038","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2021.06.007_bib0039","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1097\/j.pain.0000000000001299","article-title":"Sensory sensitivity and symptom severity represent unique dimensions of chronic pain: a MAPP Research Network study","volume":"159","author":"Schrepf","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2021.06.007_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: A large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Perm J"},{"key":"10.1016\/j.jpain.2021.06.007_bib0041","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","article-title":"Nabilone for the treatment of pain in fibromyalgia","volume":"9","author":"Skrabek","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2021.06.007_bib0042","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","article-title":"An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia","volume":"160","author":"van de Donk","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2021.06.007_bib0043","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3389\/fpsyt.2020.624012","article-title":"A multiple correspondence analysis of patterns of CBD use in hemp and marijuana users","volume":"11","author":"Vilches","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jpain.2021.06.007_bib0044","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2021.06.007_bib0045","first-page":"45","article-title":"Cannabinoid, terpene, and heavy metal analysis of 29 over-the-counter commercial veterinary hemp supplements","volume":"11","author":"Wakshlag","year":"2020","journal-title":"Vet Med (Auckl)"},{"key":"10.1016\/j.jpain.2021.06.007_bib0046","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","article-title":"The effects of nabilone on sleep in fibromyalgia: Results of a randomized controlled trial","volume":"110","author":"Ware","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpain.2021.06.007_bib0047","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/PSY.0b013e31827264aa","article-title":"Functional somatic syndromes: sensitivities and specificities of self-reports of physician diagnosis","volume":"74","author":"Warren","year":"2012","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jpain.2021.06.007_bib0048","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1111\/j.1464-410X.2012.11422.x","article-title":"Prognostic factors for recent-onset interstitial cystitis\/painful bladder syndrome","volume":"111","author":"Warren","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.jpain.2021.06.007_bib0049","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.urology.2008.06.031","article-title":"Antecedent nonbladder syndromes in case-control study of interstitial cystitis\/painful bladder syndrome","volume":"73","author":"Warren","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.jpain.2021.06.007_bib0050","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1080\/10826084.2020.1729201","article-title":"CBD (Cannabidiol) product attitudes, knowledge, and use among young adults","volume":"55","author":"Wheeler","year":"2020","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.jpain.2021.06.007_bib0051","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: A systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2021.06.007_bib0052","doi-asserted-by":"crossref","DOI":"10.1111\/jabr.12135","article-title":"Phenotypic features of central sensitization","volume":"23","author":"Williams","year":"2018","journal-title":"J Appl Biobehav Res"},{"key":"10.1016\/j.jpain.2021.06.007_bib0053","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.rdc.2009.05.007","article-title":"Advances in the assessment of fibromyalgia","volume":"35","author":"Williams","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jpain.2021.06.007_bib0054","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2021.06.007_bib0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front Pharmacol"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590021002522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590021002522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:05:53Z","timestamp":1761509153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590021002522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1526590021002522"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2021.06.007","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2021.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by United States Association for the Study of Pain, Inc.","name":"copyright","label":"Copyright"}]}}